BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36797689)

  • 1. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
    Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
    BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index.
    Al-Keilani MS; Elstaty R; Alqudah MA
    Int J Breast Cancer; 2022; 2022():4987912. PubMed ID: 35419208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of PKM2 Expression With HER2/neu and Additional Breast Cancer Biomarkers and its Prognostic Significance.
    Al-Qudah MA; Al-Keilani MS; Obeidat M; Haddad HK; Bdeir R; Samman LM
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):363-370. PubMed ID: 37212690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
    Al-Keilani MS; Elstaty RI; Alqudah MA; Alkhateeb AM
    PLoS One; 2021; 16(6):e0252616. PubMed ID: 34086748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
    Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
    Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
    Davoodian M; Boroumand N; Mehrabi Bahar M; Jafarian AH; Asadi M; Hashemy SI
    Mol Biol Rep; 2019 Feb; 46(1):1285-1293. PubMed ID: 30684188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
    Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
    Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
    Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
    Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
    Ebrahimi S; Javid H; Alaei A; Hashemy SI
    Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers.
    Ono M; Tsuda H; Yunokawa M; Yonemori K; Shimizu C; Tamura K; Kinoshita T; Fujiwara Y
    Breast Cancer; 2015 Mar; 22(2):141-52. PubMed ID: 23584595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
    Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
    Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
    Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
    Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
    Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
    Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.
    Gharaee N; Pourali L; Jafarian AH; Hashemy SI
    Mol Biol Rep; 2018 Dec; 45(6):2257-2262. PubMed ID: 30225581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
    Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
    Wang F; Liu S; Liu J; Feng F; Guo Y; Zhang W; Zheng G; Wang Q; Cai L; Guo M; Lian X; Xu G; Zhang H
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1210-1216. PubMed ID: 31109645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic value.
    Sánchez-Muñoz A; Plata-Fernández YM; Fernández M; Jaén-Morago A; Fernández-Navarro M; de la Torre-Cabrera C; Ramirez-Tortosa C; Lomas-Garrido M; Llácer C; Navarro-Perez V; Alba-Conejo E; Sánchez-Rovira P
    Clin Breast Cancer; 2013 Apr; 13(2):146-52. PubMed ID: 23318089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.